LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Atara Biotherapeutics Inc

Closed

SectorHealthcare

8.97 7.81

Overview

Share price change

24h

Current

Min

8.22

Max

9.19

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.05% upside

Dividends

By Dow Jones

Next Earnings

8 Aug 2025

News Sentiment

By Acuity

50%

50%

167 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Atara Biotherapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Mar 2025, 21:54 UTC

Earnings

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

16 Jan 2025, 16:17 UTC

Major Market Movers

Atara Shares Sink After FDA Stalls Cancer Treatment

16 Jan 2025, 14:31 UTC

Major Market Movers

FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

20.05% upside

12 Months Forecast

Average 10 USD  20.05%

High 17 USD

Low 3 USD

Based on 3 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

7.245 / 7.64Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

167 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$